Cancer Gene Therapy Market by Therapy, Indication, End-Use

List of Tables

The Cancer Gene Therapy Market was valued at USD 2.20 billion in 2023, expected to reach USD 2.75 billion in 2024, and is projected to grow at a CAGR of 20.22%, to USD 7.99 billion by 2030.

Cancer gene therapy is a revolutionary approach that aims to treat or prevent cancer by altering the genetic instructions within a person's cells. This therapy involves methods like inserting a healthy copy of a malfunctioning gene, knocking out a gene that's causing issues, or introducing a new gene to help fight the disease. The necessity for cancer gene therapy lies in its potential to provide personalized treatment options, improve survival rates, and reduce the systemic side effects commonly associated with traditional cancer treatments. Its applications are diverse and primarily include precision oncology, targeted drug delivery, and regenerative medicine. End-users span across hospitals, clinics, and research institutes, highlighting the vast scope of this market.

KEY MARKET STATISTICS
Base Year [2023]	USD 2.20 billion
Estimated Year [2024]	USD 2.75 billion
Forecast Year [2030]	USD 7.99 billion
CAGR (%)	20.22%

The market growth of cancer gene therapy is driven by advancements in genetic engineering technologies, increased funding for genomic research, and rising awareness regarding personalized medicine. The development of CRISPR-Cas9 and other advanced gene-editing tools has expanded potential applications, making gene therapy more accessible and effective. Moreover, the increasing incidence of cancer globally and the limitations of conventional treatments perpetuate the demand for innovative solutions. However, challenges, including high costs, regulatory hurdles, ethical concerns, and the complex nature of gene therapy, pose barriers to market growth.

Opportunities are ripe in expanding research and development investments, especially focusing on the latent potential of RNA-guided gene editing and CAR T-cell therapies. Collaborative efforts between biotech firms and academic institutions can foster innovation. Market players should focus on awareness campaigns and build strong alliances with healthcare systems to expedite market penetration. Businesses can also explore partnerships for cost-sharing and risk mitigation strategies to overcome financial barriers. However, ongoing vigilance for potential side effects and carefully navigating the ethical landscape is crucial for sustainable growth. The cancer gene therapy market is poised for growth, with innovation at the helm, necessitating continuous research, strategic alliances, and robust regulatory frameworks to maximize market potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Gene Therapy Market

The Cancer Gene Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Need for treatment options to tackle the growing prevalence of cancers
- Increasing R&D activities to stimulate cancer research
- Government support for the development of cancer treatment methods and gene therapy
Market Restraints
- Risk of adverse immune reaction and recall of products
Market Opportunities
- Expansion of gene therapy cancer centers worldwide
- Utilization of AI and ML to accelerate cell and gene therapies
Market Challenges
- Regulatory considerations concerning the safety of gene therapy

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Gene Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Gene Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Gene Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Gene Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Gene Therapy Market

A detailed market share analysis in the Cancer Gene Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Gene Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Gene Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Gene Therapy Market

A strategic analysis of the Cancer Gene Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Gene Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., Achieve Life Sciences, Inc., Adaptimmune Therapeutics PLC, Alaunos Therapeutics Inc., Amgen, Inc., Bayer AG, Biogen Inc., Bluebird Bio Inc., Bristol-Myers Squibb Company, Candel Therapeutics, Elevate Bio Inc., Genelux Corporation, Gilead Sciences, Inc., GlaxoSmithKline Inc., ImmunityBio, Inc., Merck KGaA, Precigen, Inc., Sarepta Therapeutics, Inc., Shanghai Sunway Biotech Co., Ltd., and Sibiono GeneTech Co. Ltd..

Market Segmentation & Coverage

This research report categorizes the Cancer Gene Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Therapy, market is studied across Gene Induced Immunotherapy, Gene Transfer, and Oncolytic Virotherapy.
Based on Indication, market is studied across Breast Cancer, Liver Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, and Prostate Cancer.
Based on End-Use, market is studied across Biopharmaceutical Companies, Diagnostic Centers, and Oncology Research Institutes.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-B1685377A6FA

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Need for treatment options to tackle the growing prevalence of cancers
  - 5.1.1.2. Increasing R&D activities to stimulate cancer research
  - 5.1.1.3. Government support for the development of cancer treatment methods and gene therapy
- 5.1.2. Restraints
  - 5.1.2.1. Risk of adverse immune reaction and recall of products
- 5.1.3. Opportunities
  - 5.1.3.1. Expansion of gene therapy cancer centers worldwide
  - 5.1.3.2. Utilization of AI and ML to accelerate cell and gene therapies
- 5.1.4. Challenges
  - 5.1.4.1. Regulatory considerations concerning the safety of gene therapy
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Cancer Gene Therapy Market, by Therapy

6.1. Introduction
6.2. Gene Induced Immunotherapy
6.3. Gene Transfer
6.4. Oncolytic Virotherapy

7. Cancer Gene Therapy Market, by Indication

7.1. Introduction
7.2. Breast Cancer
7.3. Liver Cancer
7.4. Lung Cancer
7.5. Ovarian Cancer
7.6. Pancreatic Cancer
7.7. Prostate Cancer

8. Cancer Gene Therapy Market, by End-Use

8.1. Introduction
8.2. Biopharmaceutical Companies
8.3. Diagnostic Centers
8.4. Oncology Research Institutes

9. Americas Cancer Gene Therapy Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cancer Gene Therapy Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cancer Gene Therapy Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abeona Therapeutics Inc.
2. Achieve Life Sciences, Inc.
3. Adaptimmune Therapeutics PLC
4. Alaunos Therapeutics Inc.
5. Amgen, Inc.
6. Bayer AG
7. Biogen Inc.
8. Bluebird Bio Inc.
9. Bristol-Myers Squibb Company
10. Candel Therapeutics
11. Elevate Bio Inc.
12. Genelux Corporation
13. Gilead Sciences, Inc.
14. GlaxoSmithKline Inc.
15. ImmunityBio, Inc.
16. Merck KGaA
17. Precigen, Inc.
18. Sarepta Therapeutics, Inc.
19. Shanghai Sunway Biotech Co., Ltd.
20. Sibiono GeneTech Co. Ltd.